Samantha Pate
Nurse Practitioner · Lynn Haven, FLNPI 1720613979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,912 and has fallen 75.5% since, to $468 in 2023. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 236 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$429
- AstraZeneca$420
- Novo Nordisk$418
- AbbVie$353
- Boehringer Ingelheim$270
- Lilly USA, LLC$267
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,800100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 25 | $429 |
| AstraZeneca | 24 | $420 |
| Novo Nordisk | 32 | $418 |
| AbbVie | 30 | $353 |
| Boehringer Ingelheim | 13 | $270 |
| Lilly USA, LLC | 15 | $267 |
| Grifols USA, LLC | 12 | $230 |
| Amarin Pharma, Inc. | 13 | $194 |
| Amgen | 10 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $139 |
| Antares Pharma, Inc. | 9 | $134 |
| Bayer | 6 | $113 |
| Pfizer | 5 | $100 |
| GSK | 7 | $97 |
| Kowa Pharmaceuticals America, Inc. | 6 | $83 |
| Eisai Inc. | 4 | $73 |
| Johnson & Johnson | 4 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Novartis | 2 | $45 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$3,800 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Lynn Haven
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.